Advertisement
Advertisement

TOVX

TOVX logo

Theriva Biologics, Inc.

0.24
USD
Sponsored
-0.01
-5.53%
Jun 24, 15:58 UTC -4
Closed
exchange

Pre-Market

0.24

0.00
+1.26%

TOVX Earnings Reports

Positive Surprise Ratio

TOVX beat 35 of 41 last estimates.

85%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.05
Implied change from Q1 26 (Revenue/ EPS)
-100.00%
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
-91.07%

Theriva Biologics, Inc. earnings per share and revenue

On May 05, 2026, TOVX reported earnings of -0.05 USD per share (EPS) for Q1 26, beating the estimate of -0.05 USD, resulting in a 1.96% surprise. Revenue reached 300.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a +0.50% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Theriva Biologics, Inc. reported EPS of -$0.05, beating estimates by 1.96%, and revenue of $300.00K, 0% as expectations.
The stock price moved up 0.5%, changed from $0.38 before the earnings release to $0.38 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 4 analysts, Theriva Biologics, Inc. is expected to report EPS of -$0.05 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement